0.84%| Prev Close: | 2.90 |
|---|---|
| Open: | 2.86 |
| Bid: | 2.83 x 100 |
| Ask: | 2.88 x 400 |
| 1y Target Est: | 3.00 |
| Beta: | 0.41 |
| Next Earnings Date: | N/A |
| Day's Range: | 2.81 - 2.90 |
|---|---|
| 52wk Range: | 1.78 - 3.84 |
| Volume: | 57,094 |
| Avg Vol (3m): | 67,527 |
| Market Cap: | 77.28M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.02 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Transition Therapeutics Management Discusses Q3 2013 Results - Earnings Call Transcriptat Seeking Alpha(Tue May 7)
- Transition Therapeutics Announces Third Quarter Fiscal 2013 Financial ResultsCNW Group(Tue May 7)
- Transition Therapeutics Announces Third Quarter Fiscal 2013 Financial ResultsPR Newswire(Tue May 7)
- Transition Therapeutics Announces Third Quarter Fiscal 2013 Financial ResultsCNW Group(Tue May 7)
- Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2013 Financial Results on Tuesday, May 7th, at 4:30 P.M. ESTCNW Group(Mon May 6)
- Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2013 Financial Results on Tuesday, May 7th, at 4:30 P.M. ESTPR Newswire(Mon May 6)
- Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2013 Financial Results on Tuesday, May 7th, at 4:30 P.M. ESTCNW Group(Mon May 6)
- 3 Healthcare Stock Stories For Tuesday Portfolio Wellnessat Wall St. Cheat Sheet(Wed May 1)
- Transition Therapeutics Still Undervalued: Good Trial Outcome Shifts Focus To Lilly Decisionat Seeking Alpha(Tue Apr 30)
- Apple’s Debt Logistics, Suncor’s Strong Quarter, and 3 Other Hot Stocksat Wall St. Cheat Sheet(Tue Apr 30)
- Transition Therapeutics Announces Results of Clinical Study of Type 2 Diabetes Drug Candidate TT-401CNW Group(Tue Apr 30)
- Transition Therapeutics Announces Results of Clinical Study of Type 2 Diabetes Drug Candidate TT-401PR Newswire(Tue Apr 30)
- Transition Therapeutics Announces Results of Clinical Study of Type 2 Diabetes Drug Candidate TT-401CNW Group(Tue Apr 30)
- Transition Therapeutics Announces Second Quarter Fiscal 2013 Financial ResultsCNW Group(Thu Feb 7)
- Transition Therapeutics Announces Second Quarter Fiscal 2013 Financial ResultsPR Newswire(Thu Feb 7)
Press Releases
- Transition Therapeutics Announces Third Quarter Fiscal 2013 Financial ResultsCNW Group(Tue May 7)
- Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2013 Financial Results on Tuesday, May 7th, at 4:30 P.M. ESTCNW Group(Mon May 6)
- Transition Therapeutics Announces Results of Clinical Study of Type 2 Diabetes Drug Candidate TT-401CNW Group(Tue Apr 30)
Must Read
- Special K churning out new products as part of shift into a weight management toolThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Shares grind higher, yen rebounds on minister's remarksReuters(1969-12-31T18:59:59GMT-05:00)
- Chesapeake Energy hires Anadarko executive as CEOReuters(1969-12-31T18:59:59GMT-05:00)
- Despite talk of Fed changing tack, investors have so far refrained from big profit-takingThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- 2 men arrested in killing of Las Vegas teen who refused to give up his iPadThe Canadian Press(1969-12-31T18:59:59GMT-05:00)